Davor Brinc
 Professor
                            Oncology                                                        
University of Toronto
                                                        Canada
                        
Biography
Davor Brinc PhD, FCACB Assistant Professor Contact information Michael Garron Hospital/ Toronto East Health Network 825 Coxwell Ave, H-wing 2nd Floor Toronto Ontario M4C 3E7 Phone: 416-469-6580 Ext: 6386 Fax: Email: davor.brinc@alumni.utoronto.ca Research location: Primary Research Area: Genetics, Genomics & Proteomics Secondary Research Area: Infectious Diseases & Immunopathology Research Statement: I am interested in projects that aim to discover biomarkers of disease or biomarkers that are informative about the patients’ response to therapy. As part of this effort, the aim is also to develop new methods for possible clinical laboratory applications, such as immuno-mass spectrometry or improved immunoassays, capable of detecting proteins with specific post-translational modifications, isoforms, or activity. Davor Brinc PhD, FCACB Assistant Professor Contact information Michael Garron Hospital/ Toronto East Health Network 825 Coxwell Ave, H-wing 2nd Floor Toronto Ontario M4C 3E7 Phone: 416-469-6580 Ext: 6386 Fax: Email: davor.brinc@alumni.utoronto.ca Research location: Primary Research Area: Genetics, Genomics & Proteomics Secondary Research Area: Infectious Diseases & Immunopathology Research Statement: I am interested in projects that aim to discover biomarkers of disease or biomarkers that are informative about the patients’ response to therapy. As part of this effort, the aim is also to develop new methods for possible clinical laboratory applications, such as immuno-mass spectrometry or improved immunoassays, capable of detecting proteins with specific post-translational modifications, isoforms, or activity.
Research Interest
I am interested in projects that aim to discover biomarkers of disease or biomarkers that are informative about the patients’ response to therapy. As part of this effort, the aim is also to develop new methods for possible clinical laboratory applications, such as immuno-mass spectrometry or improved immunoassays, capable of detecting proteins with specific post-translational modifications, isoforms, or activity.

